NCT06689566View on ClinicalTrials.gov

Evaluating Metabolic and Anti-inflammatory Effect of Genistein on Post-myocardial Infarction Patients

NARecruitingINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Myocardial Infarction (MI)
Interventions
DIETARY_SUPPLEMENT

genistein

the patients will receive genistein 250mg BID orally for complete 3 months. Afterwards, there will be 3 months washout period. Patients would then be followed for outcome measurement.

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT06689566 - Evaluating Metabolic and Anti-inflammatory Effect of Genistein on Post-myocardial Infarction Patients | Biotech Hunter | Biotech Hunter